Neuropathy and type 1 diabetes mellitus

Pediatric Endocrinology, Diabetes and Metabolism

Volumn 14, Issue 2, 2008, Pages 109-116

  Otto Buczkowska, Ewa ^a,c   Kazibutowska, Zofia ^b   Sołyk, Jacek ^b   Machnica, Łukasz ^a  

^a Upper Silesia Centre for Child's Health   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c NONE   (Poland)

Author keywords

Cardiovascular autonomic dysfunction; Classification of the diabetic neuropathy autonomic neuropathy; Diabetes mellitus type 1; Diabetic gastroparesis; Diabetic neuropathy; Hypoglycemia unawareness; Peripheral neuropathy

Indexed keywords

ANTICONVULSIVE AGENT; BENFOTIAMINE; BETHANECHOL; CISAPRIDE; DOMPERIDONE; ERYTHROMYCIN; FLUDROCORTISONE; LEVACECARNINE; METOCLOPRAMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OPIATE; PLACEBO; RUBOXISTAURIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANALGESIA; AUTONOMIC NEUROPATHY; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; DIABETIC NEUROPATHY; DISEASE SEVERITY; ELECTROMYOGRAM; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MICROCIRCULATION; NERVE CONDUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; REVIEW; STOMACH PARESIS;

EID: 84904847530     PISSN: 1234625X     EISSN: 20838441     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Boulton A.J.M., Vinik A.I., Arezzo J.C. et al.: Diabetic neuropaties. A statement by the American Diabetes Association. Diabetes Care, 2005, 28, 956-962.
2. OttoBuczkowska E.: Neuropatia cukrzycowa - autonomiczna i obwodowa. [in:] Cukrzyca typu 1. E. Otto-Buczkowska (ed.), Cornetis, Wrocław 2006, 338-362.
3. Said G.: Diabetic neuropathy - a review. Nat. Clin. Pract. Neurol., 2007, 3, 331-340.
4. Sinnreich M., Taylor B.V., Dyck P.J.: Diabetic neuropathies. Classification, clinical features, and pathophysiological basis. Neurologist, 2005, 11, 63-79.
5. Kazibutowska Z.: Polyneuropathy and motor nerve conduction velocity in children and adolescents with diabetes mellitus. Neurol. Neurochir. Pol., 1974, 8, 519-524.
6. Kozek E., Górska A., Fross K. et al.: Chronic complications and risk factor in patients with type 1 diabetes mellitus - a retrospective analysis. Przegl. Lek., 2003, 60, 773-777.
7. Soedamah-Muthu S.S., Chaturvedi N., Witte D.R. et al. The EURODIAB Prospective Complications Study Group: The relationship between risk factors and mortality in type 1 diabetic patients in Europe, the EURODIAB Prospective Complications Study (PCS). Diabetes Care, 2008.
8. Otto M., Bak S., Bach F.W. et al.: Pain phenomena and possible mechanism in patients with painful polyneuropathy. Pain, 2003, 101, 187-192.
9. Boulton A.J.K., Malik R.A., Arezzo J.C., Sosenko J.M.: Diabetic somatic neuropathies. Diabetes Care, 2004, 27, 1458-1486.
10. Vinik A.I., Mehrabyan A.: Diabetic neuropathies. Med. Clin. North Am., 2004, 88, 947-999.
11. Weintrob N., Amitay I., Lilos P. et al.: Bedside neuropathy disability score compared to quantitative sensory testing for measurement of diabetic neuropathy in children, adolescents, and young adults with type 1 diabetes. J. Diabetes Complications, 2007, 21, 13-19.
12. Position Statement. Original Article. American Diabetes Association standards of medical care in diabetes. Diabetes Care, 2006, 29, S4-S42.
13. Riihimaa P.H., Suominen K., Talonen U. et al.: Peripheral nerve function is increasingly impaired during puberty in adolescents with Type 1 Diabetes. Diabetes Care, 2001, 24, 1087-1092.
14. Targut N., Karasihoglu S., Kücükugurluoglu J. et al.: Clinical utility of dorsal sural nerve conduction studies in healthy and diabetic children. Clin. Neurophysiol., 2004, 115, 1452-1456.
15. Dyck P.J., Davies J.L., Litchy W.J., O'Brien P.C.: Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study Cohort. Neurology, 1997, 49, 229-239.
16. Mohsin F., Craig M.E., Cusumano J. et al.: Discordant trends in microvascular complications in adolescents with Type 1 Diabetes. Diabetes from 1990 to 2002. Diabetes Care, 2005, 28, 1974-1980.
17. Karavanaki K., Baum J.D.: Coexistence of impaired indices of autonomic neuropathy and diabetic nephropathy in a cohort of children with type 1 diabetes mellitus. J. Pediatr. Endocrinol. Metab., 2003, 16, 79-90.
18. Lafferty A.R., Werther G.A., Clarke C.F.: Ambulatory blood pressure, microalbuminuria and autonomic nephropathy in adolescents with type 1 diabetes. Diabetes Care, 2000, 23, 533-538.
19. Varechova S., Durdik P., Cervenkova V. et al.: The influence of autonomic neuropathy on cough reflex sensitivity in children with diabetes mellitus type 1. J. Physiol. Pharmacol., 2007, 58, suppl. 5 (Pt 2), 705-715.
20. Verrotti A., Giuva P.T., Morgese G., Chiarelli F.: New trends in the etiopathogenesis of diabetic peripheral neuropathy. J. Child. Neurol., 2001, 16, 389-394.
21. Forsén A., Kangro M., Sterner G. et al.: 14-year prospective study of autonomic nerve function in type 1 diabetic patients: association with nephropathy. Diabet. Med., 2004, 21, 852-858.
22. Karavanaki K., Baum J.D.: Prevalence of microvascular and neurologic abnormalities in a population of diabetic children. J. Pediatr. Endocrinol. Metab., 1999, 12, 411-422.
23. Greene D.A., Arezzo J.C., Brown M.B.: Effect of aldose reductase inhibition on nerve conduction and morfometry in diabetic neuropathy: Zenarestat Study Group. Neurology, 1999, 53, 580-591.
24. Pappachan J.M., Sebastian J., Bino B.C. et al.: Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis. Postgrad. Med. J., 2008, 84, 205-210.
25. Karamitsos T.D., Karvounis H.I., Didangelos T. et al.: Impact of autonomic neuropathy on left ventricular function in normotensive type 1 diabetic patients: a tissue Doppler echocardiographic study. Diabetes Care, 2008, 31, 325-327.
26. Palmieri V., Capaldo B., Russo C. et al.: Uncomplicated type 1 diabetes and preclinical left ventricular myocardial dysfunction: insights from echocardiography and exercise cardiac performance evaluation. Diabetes Res. Clin. Pract., 2008, 79, 262-268.
27. Ostoya J., Mertens D.: Exertional hypotension: the possible role of cardiovascular autonomic neuropathy. J. Cardiopulm. Rehabil., 2006, 26, 319-322.
28. Vinik A.: Use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy. J. Clin. Endocrinol. Metab., 2005, 90, 4936-4945.
29. Chessa M., Butera G., Lanza G.A. et al.: Role of heart rate variability in the ear ly diagnosis of diabetic autonomic neuropathy in children. Herz, 2002, 27, 785-790.
30. Karavanaki-Karanassiou K.: Autonomic neuropathy in children and adolescents with diabetes mellitus. J. Pediatr. Endocrinol. Metab., 2001, 14, suppl. 5, 1379-1386.
31. Trotta D., Verrotti A., Salladini C., Chairelli F.: Diabetic neuropathy in children and adolescents. Pediatr. Diabetes, 2004, 5, 44-57.
32. Massin M.M., Derkene B., Tallsund M. et al.: Cardiac autonomic dysfunction in diabetic children. Diabetes Care, 1999, 22, 1845-1850.
33. Boysen A., Lewin M.A., Hecker W. et al.: Autonomic function testing in children and adolescents with diabetes mellitus. Pediatr. Diabetes, 2007, 8, 261-264.
34. Horowitz M., O'Donovan D., Jonem K.L. et al.: Gastric emptying in diabetes: clinical significance and treatment. Diabet. Med., 2002, 19, 177-194.
35. Punkkinen J., Färkkilä M., Mätzke S. et al.: Upper abdominal symptoms in patients with type 1 diabetes: unrelated to impairment in gastric emptying caused by autonomic neuropathy. Diabet. Med., 2008, 25, 570-577.
36. Arslanoglu I., Unal F., Sagin F. et al.: Real-time sonography for screening of gallbladder dysfunction in children with type 1 diabetes mellitus. J. Pediatr. Endocrinol. Metab., 2001, 14, 61-69.
37. Brown J.S., Wessells H., Chancellor M.B. et al.: Urologic complications of diabetes. Diabetes Care, 2005, 28, 177-185.
38. Szabo L., Barkai L., Lombay B.: Urinary flow disturbance as an early sign of autonomic neuropathy in diabetic children and adolescents. Neurourol. Urodyn., 2007, 26, 218-221.
39. Meyer C., Grossmann R., Mitracou A. et al.: Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients. Diabetes Care, 1998, 21, 1960-1966.
40. Cryer P.E.: Hypoglycemia - associated autonomic failure in diabetes. Am. J. Physiol. Endocrinol. Metab., 2001, 281, E 1115-1121
41. Maguire A.M., Craig M.E., Craighead A. et al.: Autonomic nerve testing predicts the development of complications: a 12-year follow-up study. Diabetes Care, 2007, 30, 77-82.
42. Karachaliou F., Karavanaki K., Greenwood R., Baum J.D.: Consistency of papillary abnormality in children and adolescents with diabetes. Diabet. Med., 1997, 14, 849-853.
43. Várkonyi T.T., Börcsök E., Tóth F. et al.: Severity of autonomic and sensory neuropathy and the impairment of visual- and auditory-evoked potentials in type 1 diabetes: is there a relationship? Diabetes Care, 2006, 29, 2325-2326.
44. Chaudhuri K.R., Wren D.R., Werring D., Watkins P.J.: Unilateral abdominal muscle herniation with pain: a distinctive variant of diabetic radiculopathy. Diabet. Med., 1997, 14, 803-807.
45. Perkins B.A., Olaleye D., Bril V.: Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care, 2002, 25, 565-569.
46. Dyck P.J.B.: Radiculoplexus neuropathies: diabetic and nondiabetic varietes. [in:] Peripheral neuropathy. 4 ed. P.J. Dyck, P.K. Thomas (eds.), Elsevier Saunders, Philadelphia 2005, 2, 1993-2015.
47. Toyokura M., Ishida A.: Diagnostic sensitivity of predicted F-wave latency by age, height and MCV. Acta Neurol. Scand., 2000, 102, 106-113.
48. Onde M.E., Ozge A., Senol M.G. et al.: The sensitivity of clinical diagnostic methods in the diagnosis of diabetic neuropathy. J. Int. Med. Res., 2008, 36, 63-70.
49. Oyer D.S., Saxon D., Shah A.: Quantitative assessment of diabetic peripheral neuropathy with use of the clanging tuning fork test. Endocr. Pract., 2007, 13, 5-10.
50. Abad F., Diaz-Gomez N.M., Rodriguezt I. et al.: Subclinical pain and thermal sensory dysfunction in children and adolescents with type 1 diabetes mellitus. Diabet. Med., 2002, 19, 827-831.
51. Shy M.E., Frohman E., So Y.T. et al.: Subcommittee of the American Academy of Neurology quantitative sensory testing. Neurology, 2003, 602, 898-906.
52. Vinik A.I., Erbas T.: Recognizing and treating diabetic autonomic neuropathy. Cleve Clin. J. Med., 2001, 68, 928-944.
53. Vinik A.I., Freeman R., Erbas T.: Diabetic autonomic neuropathy. Semin. Neurol., 2003, 23, 365-372.
54. Suys B.E., Huybrechts S.J., De Wolf D. et al.: QTc interval prolongation and QTc depression in children and adolescents with type 1 diabetes. J. Pediatr., 2002, 141, 59-63.
55. Javorka M., Trunkvalterova Z., Tonhajzerova I. et al.: Short-term heart rate complexity is reduced in patients with type 1 diabetes mellitus. Clin. Neurophysiol., 2008, 119, 1071-1081.
56. Markuszewski L., Ruxer J., Michałkiewicz D., Bissinger A.: Zaburzenia ciśnienia tȩtniczego i parametrów spektralnej analizy zmienności rytmu serca w odpowiedzi na pionizacjȩ u chorych na cukrzycȩ typu 1. Folia Cardiol. Exc., 2006, 1, 305-311
57. Gerritsen J., Dekker J.M., Ten Voorde B.J. et al.: Glucose tolerance and other determinants of cardiovascular autonomic function: the Horn Study. Diabetologia, 2000, 43, 561-570.
58. King R.H.: The role of glycation in the pathogenesis of diabetic polyneuropathy. Molecular Pathology, 2001, 54, 400-408.
59. Nishikawa T., Edelstein D., Du X.L. et al.: Normalizing mitochondrial superoxide productions blocks three pathways of hyperglycemic damage. Nature, 2001, 404, 787-790.
60. Malik R.A., Williamson S., Abbot C.A. et al.: Effect of angiotensin-converting enzyme (ACE) inhibitor trandalopril on human diabetic neuropathy: randomized double-blind controlled trial. Lancet, 1998, 352, 1978-1998.
61. Cameron N.E., Eaton S.E.M., Cotter M.A., Tesfaye S.: Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia, 2001, 44, 1973-1988.
62. Quattrini C., Harris N.D., Malik R.A., Tesfaye S.: Impaired skin microvascular reactivity in painful diabetic neuropathy. Diabetes Care, 2007, 30, 655-659.
63. Giannopoulos S., Pelidou S.H., Kyritsis A.P., Kosmidou M.: Burden of illness in painful diabetic peripheral neuropathy. J. Pain, 2007, 8, 530.
64. DCCT Research Group: The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complication Trial (DCCT). Diabetologia, 1998, 41, 416-423.
65. Hotta N., Toyota T., Matsuoka K. et al.: Clinical efficacy of tidarestatt, a nerval aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week, multicenter placebo-controlled double-blind parallel group study. Diabetes Care, 2001, 24, 1776-1782.
66. Ametov A.S., Barinow A., Dyck P.J. et al.: The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care 2003, 26, 770-776
67. Ziegler D., Nowak H., Kempler P. et al.: Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet. Med., 2004, 21, 114-121.
68. Vinik A.I., Maser R.E., Mitchell B.D., Freeman R.: Diabetic autonomic neuropathy. Diabetes Care, 2003, 26, 1553-1579.
69. Ekberg K., Brismar T., Johansson B.L. et al.: C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy. Diabetes Care, 2007, 30, 71-76.
70. Ekberg K., Johansson B.L.: Effect of C-peptide on diabetic neuropathy in patients with type 1 diabetes. Exp. Diabetes Res., 2008, 2008, 457912.
71. Kamiya H., Zhang W., Ekberg K. et al.: C-Peptide reverses nociceptive neuropathy in type 1 diabetes. Diabetes, 2006, 55, 3581-3587.
72. Sima A.A.F., Calvani M., Mehra M., Amata A.: Acethyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy. Diabetes Care, 2005, 28, 89-94.
73. Cameron N.E., Gibson T.M., Nangle M.R., Cotter M.A.: Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes. Ann. N. Y. Acad. Sci., 2005, 1043, 784-792.
74. Haupt E., Lederman H., Köpecke W.: Benfotiamine in the treatment of diabetic polyneuropathy - a three-week randomised controlled pilot study (BEDIP Study). Int. J. Clin. Pharmacol. Ther., 2005, 43, 71-77.
75. Casellini C.M., Barlow P.M., Rice A.L. et al.: A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy. Diabetes Care, 2007, 30, 896-902.
76. Chong M.S., Hester J.: Diabetic painful neuropathy: current and future treatment options. Drugs, 2007, 67, 569-585.
77. Wong M.-C., Chung J.W.Y., Wong T.K.S.: Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. BMJ, 2007, 335, 87.
78. Restivo D.A., Marchese-Ragona R., Lauria G. et al.: Botulinum toxin treatment for oropharyngeal dysphagia associated with diabetic neuropathy. Diabetes Care, 2006, 29,2650-2653.